Newly constructed 284-unit luxury community in Madison represents the final acquisition in the firm's first commingled fund, showcasing strategic execution in growing Sun Belt markets.
Read More
New guide outlines a proven roadmap to simplify delivery, embrace Microsoft's AI-powered platform, and future-proof project and work management operations
Read MoreAs announced, initial proof-of-concept (POC) results from distinct ongoing investigator-initiated trial (IIT) in Abu Dhabi show crofelemer reduced total parenteral support in a pediatric MVID patient with intestinal failure by up to 27%; per the IIT protocol, patient was taken off crofelemer after 12 weeks of treatment for a period of 30 days, but was restarted on daily crofelemer treatment after just 8 days, as patient's symptoms were worsening
Additional POC IIT results expected throughout 2025 for MVID; results from company's MVID Phase 2 study expected with completion of treatment in H2 2026
Ground-breaking results in single-digit number of MVID patients could potentially lead to expedited approval in the EU through PRIME and to Breakthrough Therapy designation in the US
Read More
Hosted by Anthony Anderson & Aisha Tyler, the Parade Features Hollywood Stars and Performances by Scotty Hasting, Restless Road and Musicians From the United States Military
Read More
The partnership is an ideal fit for both the silversmith brand and Western Vaca, a Mexico-based influencer that perfectly aligns with the style and sentiment of The Most Wanted Custom Silver's artisan jewelry products.
Read More
New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL's global manufacturing and expertise.
Read More
The sam® sustained acoustic medicine device can help millions of people suffering from knee osteoarthritis to find relief, without invasive surgery or potentially addictive painkiller medications.
Read More
During its annual Evening of Excellence ceremony, the MCPSEF awarded nearly 200 scholarships and awards including CSIOS Corporation's Cesar Pie Cyber Defender Scholarship.
Read MoreTrial marks key milestone in driving pipeline progress
Phase 1 trial scheduled for completion mid-June 2025
Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback
Read MoreKey Regulatory Milestone Provides Clear Development Roadmap to Registration for MOTYS
Initiation of Phase 3 Program Remains on Schedule to Begin in Q3 2025
Company Updates Investor Presentation to Reflect Strong Q1 Earnings, More than $20M in Pro Forma Revenue and 15% Increase in 2025 Pro Forma Revenue Guidance
Read More